This is a randomized, two-arm, parallel-group pilot trial investigating a new chatbot tool designed to support cancer patients and caregivers, particularly those in rural communities. Approximately 60 participants will be randomized 1:1 to interact with either a hybrid chatbot or an AI-enabled chatbot. Participants will use their assigned chatbot to obtain clear and helpful information related to insurance, travel costs, and other financial aspects of cancer care.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Single-Item Helpfulness Rating
Timeframe: up to 2 weeks
System Usability Scale (SUS)
Timeframe: up to 2 weeks
Acceptability of Intervention Measure (AIM)
Timeframe: up to 2 weeks
Chatbot User Satisfaction (CUS) - Satisfaction Subscale
Timeframe: up to 2 weeks
Trust in Automated Systems Test (TOAST)
Timeframe: up to 2 weeks